Early engraftment and full-donor chimerism after single-cord blood plus third-party donor dual transplantation in patients with high-risk acute leukemia.
1] Department of Haematology, Catalan Institute of Oncology (ICO)-Hospital Duran i Reynals, Barcelona, Spain [2] Group of Hematological Malignancies, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
I
I
Sánchez-Ortega
1] Department of Haematology, Catalan Institute of Oncology (ICO)-Hospital Duran i Reynals, Barcelona, Spain [2] Group of Hematological Malignancies, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
M
M
Arnan
1] Department of Haematology, Catalan Institute of Oncology (ICO)-Hospital Duran i Reynals, Barcelona, Spain [2] Group of Hematological Malignancies, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
B
B
Patiño
Laboratori d'Immunobiologia per a la Reçerca i Aplicacions Diagnòstiques (LIRAD), Banc de Sang i Teixits, Barcelona, Spain.
M J
MJ
Herrero
Cell Therapy Unit and Cord Blood Bank, Banc de Sang i Teixits, Barcelona, Spain.
S
S
Querol
1] Department of Haematology, Catalan Institute of Oncology (ICO)-Hospital Duran i Reynals, Barcelona, Spain [2] Group of Hematological Malignancies, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
R F
RF
Duarte
D000328:Adult; D015331:Cohort Studies; D036101:Cord Blood Stem Cell Transplantation / Q000379:methods*; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D012008:Recurrence; D018183:Transplantation Chimera / Q000276:immunology*; D019172:Transplantation Conditioning; D016896:Treatment Outcome; D055815:Young Adult